Mc2 Therapeutics Limited

3 trials Commercial sponsor

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

2 Completed trials

4 Countries active

1 Unique IMPs

100% Results reported

Phase II

100%

2 of 2 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

ALANYL GLUTAMINE 3

All trials

3 total

A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in… Not authorised

2022-500044-38-00 Phase II 3 countries ALANYL GLUTAMINE
Orchid 1 Ended

2023-503516-32-00 Phase II 1 country ALANYL GLUTAMINE
A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in… Ended

2022-500044-38-01 Phase II 3 countries ALANYL GLUTAMINE

Showing 1–3 of 3 trials

← All sponsors A–Z